Table 3. Lymphocyte subsets and NK cells levels comparison within the case group.
| CD8+ | CD19+ | NK | |
|---|---|---|---|
| Genders | |||
| Male | 30.1 ± 10.2* | 3.0 ± 2.6* | 16.1 ± 8.4* |
| Female | 25.9 ± 9.7 | 3.3 ± 2.4 | 13.6 ± 8.0 |
| Tumor numbers | |||
| Singly | 28.9 ± 10.1 | 3.0 ± 2.6 | 15.6 ± 8.3 |
| Multiply | 29.2 ± 10.2 | 3.0 ± 2.6 | 15.8 ± 8.3 |
| TNM stages | |||
| I–II | 25.6 ± 9.8 | 3.3 ± 2.4 | 13.5 ± 8.0 |
| III–IV | 30.1 ± 10.1* | 2.9 ± 2.7* | 16.3 ± 8.3* |
| Child-Pugh | |||
| A | 27.5 ± 9.7 | 3.1 ± 2.5 | 14.8 ± 7.8 |
| B | 28.7 ± 10.0 | 3.0 ± 2.6 | 14.3 ± 8.0 |
| C | 29.0 ± 10.0 | 3.1 ± 2.6 | 15.6 ± 8.1 |
| Extrahepatic metastasis | |||
| With | 30.1 ± 9.7* | 3.1 ± 2.6* | 15.9 ± 8.2* |
| Without | 25.5 ± 9.4 | 3.3 ± 2.7 | 11.8 ± 7.7 |
| Infection | |||
| HBV infection | 29.3 ± 10.2* | 3.0 ± 2.6* | 16.0 ± 8.4* |
| HCV infection | 26.1 ± 9.5 | 3.3 ± 2.9 | 12.3 ± 8.0 |
Note:
*
compared between groups, P < 0.05. Hepatitis B virus; HCV, hepatitis C virus.